FDA Brief

Company record

Artivion, Inc

0 FDA warning letters since 2023 and 1 recall in the last 12 months.

Get an email the day FDA posts anything new about Artivion, Inc.

Recalls

ReportedClassFirmProduct and reason
Nov 11 Class II Artivion, Inc
Device
CryoPatch SynerGraft (SG) Pulmonary Human Cardiac Patch, Model: SGP010
A cryopreserved pulmonary human cardiac patch, taken from a 64-year-old human donor, was outside the cardiac tissue donor age specification of newborn to 60 years. The patch was implanted, and due to limitations of long-term in vivo data, the possibility of premature graft dysfunction cannot be excluded.